Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (806968)
Novo Nordisk Fonden (NNF21OC0069821)
Region Zealand
Danish Ministry of Higher Education and Science
Zealand Region
Article History
Accepted: 1 October 2024
First Online: 10 October 2024
Declarations
:
: Approval for this study was obtained from the Danish Data Protection Agency under approval number REG-102–2020. Due to the retrospective nature of the study and the de-identification of patient data, ethics approval and written consent for participation were not required.
: The authors declare no competing interests.
: Not applicable.